ESR1 and cancer: In an attempt to simulate physiological conditions in the female bloodstream, with E2 naturally being present as a strong and unselective ER ligand, either endothelial and cancer cells or only endothelial cells were first differentiated with E2 for 24 h, subsequently either treated with DPN or not, and compared to the untreated control.